Update on heart failure management and future directions
The Korean Journal of Internal Medicine
; : 11-43, 2019.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-719289
Responsible library:
WPRO
ABSTRACT
Heart failure (HF) is an important cardiovascular disease because of its increasing prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. The number of HF patients is increasing worldwide, and Korea is no exception. There have been marked advances in definition, diagnostic modalities, and treatment of HF over the past four decades. There is continuing effort to improve risk stratification of HF using biomarkers, imaging and genetic testing. Newly developed medications and devices for HF have been widely adopted in clinical practice. Furthermore, definitive treatment for end-stage heart failure including left ventricular assist device and heart transplantation are rapidly evolving as well. This review summarizes the current state-of-the-art management for HF and the emerging diagnostic and therapeutic modalities to improve the outcome of HF patients.
Full text:
Available
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Goal 4: Health financing
/
Target 3.4: Reduce premature mortality due to noncommunicable diseases
/
Cardiovascular Disease
/
Other circulatory Diseases
Database:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Biomarkers
/
Cardiovascular Diseases
/
Heart-Assist Devices
/
Genetic Testing
/
Prevalence
/
Mortality
/
Heart Transplantation
/
Health Care Costs
/
Diagnosis
Type of study:
Diagnostic study
/
Prevalence study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
The Korean Journal of Internal Medicine
Year:
2019
Document type:
Article